Predictive Oncology Inc (NASDAQ:POAI) shares are trading higher by 46.6% to $2.30 during Tuesday’s session after the company announced positive results from a retrospective study conducted with UPMC ...
POAI ‘s Helomics Division Announces Progress on Milestones for its AI-Driven Model of Ovarian Cancer
MINNEAPOLIS, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug ...
Predictive Oncology Inc. (POAI) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top ...
Predictive Oncology operates at the intersection of artificial intelligence and oncology, using advanced software and a proprietary tumor biobank to assist biopharma partners in cancer drug discovery.
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Predictive Oncology, Inc. (NASDAQ:POAI) stock is trading higher on Tuesday after the company reported results from utilizing artificial intelligence (AI) for drug repurposing. The Details: Predictive ...
Predictive Oncology Inc. Annual cash flow by MarketWatch. View POAI net cash flow, operating cash flow, operating expenses and cash dividends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results